James Hughes, dean of the Bloustein School of Planning & Public Policy at Rutgers University, also said he did not see much duplication to be cut.
“Allergan has a sales staff that deals with their specific products, and Pfizer has its staff for different products. So I would think that staff is going to stay intact,” Hughes said. “It shouldn’t have much of an impact one way or the other on New Jersey.”
Wall Street Journal, November 23
On August 13, Bloustein School Distinguished Professor and Associate Dean for Research Clinton J. Andrews provided invited testimony before the New Jersey Senate Environment and Energy Committee during a hearing at the Lavallette Municipal Building focused on the need...
Patient Viewing and Comprehension of Immediately Released Test Results Introduction The 21st Century Cures Act Final Rule requires that test results be released to patients through patient portals as soon as they are available.1 Findings from studies characterizing...
New Jersey is the most densely populated state in the country, with nearly 1,300 residents per square mile, according to the 2024 Census. Four New Jersey municipalities—Guttenberg, West New York, Union City, and Hoboken—are denser than New York City. Between 1986 and...
Teachers play a vital role in both the U.S. economy and society by fostering youth development and supporting student learning throughout their K–12 education. However, the profession comes with significant challenges, beginning with the hurdles of obtaining proper...
Budget Cuts and Who Absorbs Them When budgets are cut, the first programs to go are those without dedicated funding or legal mandate. Many of those programs serve low-income, disabled, and vulnerable populations. New Jersey is in a period of fiscal austerity. The...